Skip to main content
Clinical Trials/ACTRN12607000229471
ACTRN12607000229471
Not yet recruiting
Phase 2

Participant: Individuals with osteoarthritisIntervention: Seaweed extractOutcome: Comprehensive Osteoarthritis testComparator:Dose comparison

Marinova Pty Ltd0 sites10 target enrollmentMay 1, 2007

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
Marinova Pty Ltd
Enrollment
10
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • X\-ray and clinical evidence of osteoarthritis of the kneesIn good general healthAdequate venous accessParticipants willing to discontinue their current OA (osteoarthritis) treatment for the duration of the study. This includes treatment with intra\-articular injections, corticosteroids, NSAIDs (non steroidal anti inflammatory drug), non\-prescription therapies, chondroprotective agents, occlusive dressings, physiotherapy, or orthopaedic technical measuresParticipants of childbearing age who agree to continue using birth control measures for the duration of the study.

Exclusion Criteria

  • A history of trauma associated with the affected jointRheumatoid or other inflammatory joint conditionsGoutUse of corticosteroids (intra\-articular or systematic) within 4 weeks prior to baseline and throughout the studyUse of anti\-inflammatory agents or anti\-arthritic complementary medicines 3 weeks prior to baseline and for the duration of the studyLiver function tests greater than 3 times the upper limit of normal at baselineHistory of alcohol or substance abuseFemale participants who are lactating, pregnant or planning to become pregnantParticipants who have participated in another clinical trial in the last 30 daysParticipants unwilling to comply with the study protocolAny other condition, which in the opinion of the investigators could compromise the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials